PW Medtech GroupFRA:PWE +0.95%84 Shareholder Yield % is 6.51% as of Dec. 2025, which is 64% above its 10-year median of 3.97. GuruFocus rates FRA:PWE with a GF Score™ of 84/100 and a GF Value™ of €0.13. The stock has 6 warning signs investors should review. Among 819 Medical Devices & Instruments companies, PW Medtech Group ranks better than 88.16% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, PW Medtech Group's Shareholder Yield % was 6.51%.
PW Medtech Group (FRA:PWE) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
PW Medtech Group Shareholder Yield % Related Terms
PW Medtech Group Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for PW Medtech Group's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PWE vs ISRG, BDX, MDLN: Shareholder Yield % Comparison
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group Shareholder Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
PW Medtech Group (FRA:PWE) has a Shareholder Yield % of 6.51% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on PW Medtech Group and its competitors. This is 64% above median its historical median of 3.97. According to the industry distribution chart, PW Medtech Group ranks #97 out of 819 companies in the Medical Devices & Instruments industry, placing it in the top 11.8%.
Is PW Medtech Group's Shareholder Yield % too high?
PW Medtech Group's current Shareholder Yield % of 6.51% is 64% above median its 10-year median of 3.97. The Medical Devices & Instruments industry median Shareholder Yield % is 0.17. PW Medtech Group's value of 6.51% is 3729.4% above this industry median. Based on the distribution chart, PW Medtech Group ranks #97 out of 819 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Shareholder Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #97 out of 819 companies for Shareholder Yield %. This places PW Medtech Group in the top 12% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.17. PW Medtech Group's value of 6.51% is 3729.4% above this benchmark. While the company's 10-year median is 3.97 vs. the industry median of 0.17, PW Medtech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.17, based on 819 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Shareholder Yield % of 6.51% is 3729.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Shareholder Yield % is 6.51%, which is 64% above median its own 10-year median of 3.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Shareholder Yield % of 6.51%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 18.5% below its estimated fair value. The current Shareholder Yield % is 6.51%, which is 64% above median its 10-year median of 3.97 and 3729.4% above the Medical Devices & Instruments industry median of 0.17. PW Medtech Group's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Shareholder Yield % is 6.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PW Medtech Group (FRA:PWE) Overvalued in 2026?
Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued.
The current stock price of €0.11 is trading 18.5% below its estimated GF Value™ of €0.13.
Key valuation signals for FRA:PWE:
Shareholder Yield %: 6.51% (64% above median its 10-year median of 3.97)
GF Value™: €0.13 vs. price of €0.11 (18.5% below fair value)
Industry Position: 3729.4% above the Medical Devices & Instruments median (#97 of 819)
No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
84GF Score
Get the complete analysis for FRA:PWE
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PWE has been successfully added to your 
